Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of MEDI4736 for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers (Lung-Map Sub-Study)

NCT02766335 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT02766335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02766335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of MEDI4736 for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers (Lung-Map Sub-Study)
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2014
Completion date
September 30, 2020
Enrollment
116 (actual)
Sites
993

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent squamous cell lung carcinoma, stage iv squamous cell lung carcinoma ajcc v7